Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Sebastian Berhalter passes by fallen Luis Suarez when Vancouver completed its sweep of Inter Miami ...

Will Anthony Davis, Giannis Antetokounmpo and Jonathan Kuminga switch teams this season? Illustration: Demetrius Robinson / The Athletic; Photos: Trevor Ruszkowski, Eakin Howard / Imagn Images, Stacy ...

FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8 Biomarker improvements are strongly associated with longer survival, ...

A century ago, two oddly domestic puzzles helped set the rules for what modern science treats as "real": a Guinness brewer charged with quality control and a British lady insisting she can taste ...

After decades of intense focus on genetics, the biomedical research community is undergoing a major shift, focusing on a new framework called "exposomics." Similar to the way scientists work to map ...

This study aimed to explore the correlations between organizational cynicism, burnout, and socio-demographic variables. The sample consisted of 553 Turkish Republic of Northern Cyprus (TRNC) secondary ...

A massive conservation project to track one of the most elusive predators on Earth, which resides in Jammu and Kashmir, has yielded encouraging and remarkable results. As Research Matters reports, a ...

The Bureau of Labor Statistics’ significant downward revision has sparked concerns about a weakening U.S. economy, with JPMorgan’s Jamie Dimon warning the data “confirms what we already thought.” ...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive full results from the BaxHTN Phase III trial showed baxdrostat demonstrated a statistically significant and clinically meaningful reduction in mean seated ...

Small business owners are rapidly adopting artificial intelligence to power their growth, with many saying it will lead to more job opportunities this year, according to a Goldman Sachs survey. About ...

Novartis is investigating a broad portfolio of RLTs in advanced cancers, including breast, colon, lung and pancreatic and is investing in multiple manufacturing facilities, with industry-leading ...

In its first global phase 3 readout, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody ivonescimab reduced the risk of progression or death by 48% in patients with ...